SCHEMBL6663224

SCHEMBL6663224

Cc1ccc(S(=O)(=O)N(c2ccc(OC(=O)N3CCOCC3)cc2)[C@@](C)(C(=O)O)C(=O)C2CS(=O)(=O)CCN2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPY2R P49146 4/20 0.39
RAB9A P51151 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 2/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALOX5 P09917 1/20 0.35
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
USP2 O75604 1/20 0.34
PLA2G1B P04054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6659623 0.92 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19NPY2RRAB9A
SCHEMBL6660613 0.85 NPY2R (0.35) CYP1A2CYP2C9CYP2C19NPY2RKMT2A
SCHEMBL6659012 0.85 NPY2R (0.35) CYP1A2CYP2C9CYP2C19NPY2RKMT2A
SCHEMBL6660877 0.82 NPSR1 (0.35) RAB9AKEAP1NFE2L2ALDH1A1GAA
SCHEMBL6666837 0.79 RAB9A (0.36) NPY2RRAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL3868793 0.77 CYP2C9 (0.43) CYP1A2CYP2C9CYP2C19NPY2RRAB9A
SCHEMBL6664426 0.77 ALDH1A1 (0.33) KMT2AMEN1KDM4EALDH1A1NPSR1
SCHEMBL6631941 0.77 NPY2R (0.39) CYP1A2CYP2C9CYP2C19NPY2RKMT2A
SCHEMBL5850602 0.77 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19NPY2RRAB9A
SCHEMBL3869878 0.76 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19NPY2RRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000051-B1 CARBAMYLOXY COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2004-05-19 EP claimed